申请人:NEW YORK UNIVERSITY
公开号:US11180481B2
公开(公告)日:2021-11-23
The present invention relates to oligooxopiperazines for modulating the p53-Mdm2 interaction. Exemplary oligooxopiperazines include those of Formula IA, Formula IB, and Formula IC below (wherein the various substituents are as defined herein). Methods of using the oligooxopiperazines are also disclosed.
本发明涉及用于调节 p53-Mdm2 相互作用的寡氧哌嗪。示例性的低聚氧哌嗪包括下式 IA、式 IB 和式 IC 的低聚氧哌嗪(其中各种取代基如本文所定义)。还公开了使用这些寡氧哌嗪的方法。